logo

For the Inventor, By the Inventor

South San Francisco, CA, United States of America

Roche Palo Alto LLC


USPTO Granted Patents = 322


Trademarks = 1

Forward Citations = 1,812

Loading Chart...
Loading Chart...

352 inventors (with patents filed for the assignee):

goldMedal Michael Patrick Dillon (36 out of 61 patents)

silverMedal Ronald Charles Hawley (30 out of 57 patents)

bronzeMedal David Michael Goldstein (24 out of 62 patents)

4.  Michael Soth (22 out of 30 patents)

5.  Minmin Yang (21 out of 30 patents)

6.  Li Chen (20 out of 114 patents)

7.  Lichun Feng (20 out of 33 patents)

8.  Ryan Craig Schoenfeld (20 out of 25 patents)

9.  Counde O'Yang (20 out of 38 patents)

10.  Zachary Kevin Sweeney (20 out of 75 patents)

11.  Yan Lou (19 out of 74 patents)

12.  Nolan James Dewdney (19 out of 20 patents)

13.  Francisco Xavier Talamas (19 out of 32 patents)

14.  Alam Jahangir (18 out of 29 patents)

15.  Shu-Hai Zhao (18 out of 25 patents)


Core Competencies:
Pharmacokinetics
IRAK4 Modulators
Tetralin Derivatives
P2X3 Antagonists
Amino-Methyl Tetralin
Anti-OX40L Antibodies
Benzotriazole Kinase Modulators
Pyridinyl Amides
Bruton's Tyrosine Kinase Inhibitors
Heterocyclic Antiviral Compounds
Liquid Pharmaceutical Formulations
Nucleoside Derivatives

322 patents:

1. 10918626 - Method for improving pharmacokinetics (2021-02-16),
2. 10201525 - [object Object] (2019-02-12),
3. 10023589 - Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators (2018-07-17),
4. 9896439 - [object Object] (2018-02-20),
5. 9849136 - [object Object] (2017-12-26),
6. 9670151 - Tetralin and indane derivatives and uses thereof (2017-06-06),
7. 9643934 - Process for synthesis of phenoxy diaminopyrimidine derivatives (2017-05-09),
8. 9617254 - Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonists (2017-04-11),
9. 9556127 - [object Object] (2017-01-31),
10. 9512112 - [object Object] (2016-12-06),
11. 9512089 - [object Object] (2016-12-06),
12. 9505726 - [object Object] (2016-11-29),
13. 9440956 - [object Object] (2016-09-13),
14. 9365494 - Process for synthesis of amino-methyl tetralin derivatives (2016-06-14),
15. 9308266 - Liquid pharmaceutical formulations of palonosetron (2016-04-12),
Roche Palo Alto LLC is a research and development center dedicated to discovering and developing innovative therapies to improve patients' lives. With a focus on oncology, immunology, and neurosciences, Roche Palo Alto LLC combines cutting-edge technology and scientific expertise to advance medical knowledge and create new treatment options. Learn more about our work and collaborations on our website.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
322 Patents

#5 in South San Francisco, CA

#294 in California

#1,314 in US

#2,706 in the World

...
South San Francisco, CA, United States of America

Roche Palo Alto LLC

Forward Citations = 1,812

352 inventors:

goldMedal Michael Patrick Dillon (36 out of 61 patents)

silverMedal Ronald Charles Hawley (30 out of 57 patents)

bronzeMedal David Michael Goldstein (24 out of 62 patents)

4.  Michael Soth (22 out of 30 patents)

5.  Minmin Yang (21 out of 30 patents)

Please report any incorrect information to support@idiyas.com
Loading…